Body composition parameters predict survival in pancreatic cancer—A retrospective multicenter analysis

Author:

Damm Marko1ORCID,Efremov Ljupcho23,Jalal Mustafa4,Nadeem Nabeegh4,Dober Johannes5,Michl Patrick16,Wohlgemuth Walter A.5,Wadsley Jonathan7,Hopper Andrew D.8,Krug Sebastian16,Rosendahl Jonas1

Affiliation:

1. Department of Internal Medicine I University Hospital Halle Martin‐Luther‐University Halle‐Wittenberg Halle (Saale) Germany

2. Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI) Interdisciplinary Center for Health Sciences Martin‐Luther‐University Halle‐Wittenberg Halle (Saale) Germany

3. Department of Radiation Oncology Martin‐Luther‐University Halle (Saale) Germany

4. Academic Department of Gastroenterology Royal Hallamshire Hospital Sheffield UK

5. Department of Radiology University Hospital Halle Martin‐Luther‐University Halle‐Wittenberg Halle (Saale) Germany

6. Department of Internal Medicine IV University Hospital Heidelberg Heidelberg Germany

7. Department of Oncology Weston Park Hospital Sheffield UK

8. Department of Infection and Immunity and Cardiovascular Disease University of Sheffield Sheffield UK

Abstract

AbstractBackgroundParameters to adapt individual treatment strategies for patients with pancreatic ductal adenocarcinoma (PDAC) are urgently needed. The present study aimed to evaluate body composition parameters as predictors of overall survival (OS) in PDAC patients.MethodsMeasurements of body composition parameters were performed on computed tomography scans at diagnosis. Height‐standardized and Body Mass Index‐ and sex‐adjusted regression formulas deriving cut‐offs from a healthy population were used. The Kaplan‐Meier method with the log‐rank test was performed for survival analysis. Independent prognostic factors were identified with uni‐ and multivariable Cox regression analyses.ResultsIn total, 354 patients were analyzed. In a multivariable Cox model, besides tumor stage and resection status, only myosteatosis (HR 1.53; 95% CI 1.10–2.14, p = 0.01) was an independent prognostic factor of OS among body composition parameters. Subgroup analyses revealed that the prognostic impact of myosteatosis was higher in patients ≤68 years of age, with advanced tumor stages and patients without curative intended resection.ConclusionsThe analysis of one of the largest Caucasian cohorts to date, demonstrated myosteatosis to be an independent prognostic factor of OS in PDAC. To improve outcomes, prospective trials aiming to investigate the utility of an early assessment of myosteatosis with subsequent intervention by dieticians, sports medicine physicians, and physiotherapists are warranted.

Publisher

Wiley

Subject

Gastroenterology,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3